SPDR S&P International Health Care Sector ETF (IRY)
- Global Equity | Health/Biotechnology Funds
- Loading...
Fund Description
The investment seeks investment results that, before fees and expenses, correspond generally to the total return performance of an index that tracks the health care sector of developed global markets outside the United States. The fund employs a sampling strategy in seeking to track the performance of the S&P Developed Ex-U.S. BMI Health Care Sector Index. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index or in American Depositary Receipts ("ADRs") or Global Depositary Receipts ("GDRs") based on securities comprising the index.
Fund Snapshot Updated 05.17.2013
| Previous Close | $41.05 | Expense Ratio | 0.50% |
| YTD Return | 16.4% | Avg. 30-Day Volume | 28,091 |
| 1-Year Return | 38.2% | Market Cap | Loading... |
| Bid | $41.29 | Shares Outstanding | 1,250,000 |
| Ask | $41.40 | Dividends | $0.79 |
| Top 10 Holdings | |
|---|---|
| Novartis Ag (E:NOVN) | 12.11% |
| Roche Hldgs Ag (E:ROG) | 11.20% |
| Sanofi (E:SAN) | 7.90% |
| Glaxosmithkline (E:GSK) | 7.86% |
| Bayer Ag (E:BAYN) | 5.39% |
| Novo-Nordisk As (NOVO-B) | 4.54% |
| Astrazeneca (E:AZN) | 4.53% |
| Takeda Pharmaceuti (E:4502) | 3.17% |
| Csl (E:CSL) | 2.64% |
| Astellas Pharma (E:4503) | 2.29% |
| % of Total Holdings | 61.60% |
